Left circumflex artery-related myocardial infarction: does ST elevation matter? Results from the Euro Heart Survey

Timm Bauer1, Anselm K Gitt, Matthias Hochadel

  • 1Herzzentrum Ludwigshafen, Institut für Herzinfarktforschung Ludwigshafen, Germany; Universitätsklinik Gießen, Germany.

Insights

Patients with left circumflex artery (LCX) myocardial infarction (MI) experiencing ST-elevation MI (STEMI) had higher mortality than those with non-ST-elevation MI (NSTEMI). STEMI cases often involved total occlusions and hemodynamic instability.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Left circumflex artery (LCX) myocardial infarction (MI) can present as ST-elevation MI (STEMI) or non-ST-elevation MI (NSTEMI).
  • Limited data exists on the clinical and angiographic distinctions between LCX-related STEMI and NSTEMI.
  • Understanding these differences is crucial for optimizing patient management and outcomes.

Purpose of the Study:

  • To investigate the clinical significance of ST elevations in patients with LCX-related myocardial infarction.
  • To compare angiographic and clinical characteristics of patients with LCX-related STEMI versus NSTEMI.
  • To assess the in-hospital mortality differences between these two patient groups.

Main Methods:

  • Prospective enrollment of 10,503 acute STEMI and NSTEMI patients undergoing percutaneous coronary intervention (PCI) into the Euro Heart Survey PCI-Registry (2005-2008).
  • Analysis focused on 1100 patients with LCX-related STEMI and 910 with LCX-related NSTEMI.
  • Comparison of demographic, clinical presentation, angiographic findings (TIMI flow), and in-hospital mortality.

Main Results:

  • Over 50% of LCX-related MI patients treated with PCI had STEMI.
  • STEMI patients were younger but presented more frequently with shock or after resuscitation.
  • STEMI patients had significantly higher rates of TIMI 0-1 flow before PCI (58.2% vs 25.1%).
  • Unadjusted hospital mortality showed no significant difference, but after adjustment for covariates, STEMI patients had higher mortality (OR 1.71).

Conclusions:

  • ST-elevation MI is common in LCX-related myocardial infarction.
  • LCX-related STEMI is associated with more severe coronary occlusions and hemodynamic compromise.
  • In-hospital mortality is significantly higher in patients with LCX-related STEMI compared to NSTEMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...